Wellington Management Group
RCUS icon

Wellington Management Group’s Arcus Biosciences RCUS Stock Holding History

Wellington Management Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182M Sell
5,895,448
-194,068
-3% -$4.8M 0.03% 409
2026
Q1 		$132M Buy
6,089,516
+905,007
+17% +$19.5M 0.02% 474
2025
Q4 		$124M Buy
5,184,509
+3,918,220
+309% +$79.9M 0.02% 502
2025
Q3 		$17.2M Buy
1,266,289
+330,268
+35% +$3.43M ﹤0.01% 1086
2025
Q2 		$7.62M Sell
936,021
-146,787
-14% -$1.25M ﹤0.01% 1284
2025
Q1 		$8.5M Buy
+1,082,808
New +$12.6M ﹤0.01% 1240
2019
Q4 		– Sell
-2,541,117
Closed -$23.1M – 2100
2019
Q3 		$23.1M Sell
2,541,117
-109,092
-4% -$877K 0.01% 924
2019
Q2 		$21.1M Sell
2,650,209
-1,607,497
-38% -$16.1M ﹤0.01% 994
2019
Q1 		$53.2M Sell
4,257,706
-25,628
-0.6% -$278K 0.01% 718
2018
Q4 		$46.1M Sell
4,283,334
-89,345
-2% -$1.04M 0.01% 731
2018
Q3 		$61M Sell
4,372,679
-25,183
-0.6% -$321K 0.01% 740
2018
Q2 		$53.8M Buy
4,397,862
+2,280,917
+108% +$35.8M 0.01% 765
2018
Q1 		$32.2M Buy
+2,116,945
New +$35.3M 0.01% 907

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's RCUS Position: Q2 2026 in Review

Wellington Management Group reduced its Arcus Biosciences (RCUS) stake by 3.2% in Q2 2026, selling an estimated $4.8M and leaving 5,895,448 shares worth $182M. The position accounts for 0.03% of the portfolio, ranked #409.

Wellington Management Group first reported a position in RCUS in Q1 2018 and has held it in 13 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Wellington Management Group held 5,895,448 shares of Arcus Biosciences worth $182M as of Q2 2026.
  • Wellington Management Group sold 194,068 Arcus Biosciences shares in Q2 2026, an estimated $4.8M.
  • Arcus Biosciences made up 0.03% of Wellington Management Group's portfolio in Q2 2026, its #409 holding.
  • Wellington Management Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 13 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.